The Department of Biomedical Engineering (BME) at Case Western Reserve University (CWRU) views translational research, nanotechnology, and development of biomedical and radiologic imaging as part of its vision and mission. Via the recruitment of a tenure-track Assistant Professor, we seek to investigate """"""""Image-Guided Cancer Therapeutics"""""""" by exploiting the nanoscale control in fabricating nanoparticles to design multifunctional agents that facilitate diagnosing, treating and monitoring of cancer therapies. Today's cancer therapeutics take a 'one-size-fits-all'approach to dosage and delivery of drugs, and new improved therapeutic strategies have to be explored that incorporate the technological pieces of a puzzle that can lead to customized, patient-specific therapeutic strategies. Specifically, we propose to recruit a tenure track faculty member to help unite the full spectrum of engineering, imaging and cancer expertise at CWRU. Such a program will exploit the existing strengths of the drug delivery, nanotechnology and imaging components of the BME Department, Case Center for Imaging Research, and the superb medical and basic research occurring at the School of Medicine, and the Case Comprehensive Cancer Center to develop an extremely collaborative program aimed at clinical translation and development of novel imaging tools as enablers of improved therapies in a patient-specific manner via non-invasive interrogation of tumor vasculature status. To achieve these goals, the program will utilize engineering approaches including in silico, in vitro and in vivo studies. Importantly, these tools can serve as platform technologies for other diseases where knowledge of vasculature status and integrity is of great importance (e.g. atherosclerosis, ischemia). The goal of the proposed program is to develop translational and clinically-relevant imaging technologies that non-invasively can detect and monitor (1) cancer status and (2) predict and monitor the effects of anticancer drugs in a patient-specific manner. This program will further contribute to the fast growing nanotech, cancer therapy and imaging, and medical industries of Ohio. Besides the significant impact on healthcare, this program can potentially facilitate job creation and long-term economic impacts for Ohio.

Public Health Relevance

(provided by applicant): Today's cancer therapeutics take a 'one-size-fits-all'approach, and new improved, customizable therapies have to be explored. Via the recruitment of an Assistant Professor, this program aims to integrate nanotechnology with clinically-relevant imaging to provide prognostic and monitoring tools of treatments in a patient-specific manner that enables oncologists to better differentially select therapeutic regimens.

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Center Core Grants (P30)
Project #
5P30EB011317-02
Application #
7935301
Study Section
Special Emphasis Panel (ZEB1-OSR-B (O1))
Program Officer
Baird, Richard A
Project Start
2009-09-30
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$396,513
Indirect Cost
Name
Case Western Reserve University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Bruckman, Michael A; Randolph, Lauren N; VanMeter, Allen et al. (2014) Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice. Virology 449:163-73
Shukla, Sourabh; Wen, Amy M; Ayat, Nadia R et al. (2014) Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice. Nanomedicine (Lond) 9:221-35
Lee, Karin L; Hubbard, Logan C; Hern, Stephen et al. (2013) Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct. Biomater Sci 1:
Bruckman, Michael A; Hern, Stephen; Jiang, Kai et al. (2013) Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents. J Mater Chem B 1:1482-1490
Aljabali, Alaa A A; Shukla, Sourabh; Lomonossoff, George P et al. (2013) CPMV-DOX delivers. Mol Pharm 10:3-10
Shukla, Sourabh; Ablack, Amber L; Wen, Amy M et al. (2013) Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X. Mol Pharm 10:33-42
Taghavian, Omid; Mandal, Manoj K; Steinmetz, Nicole F et al. (2012) A potential nanobiotechnology platform based on infectious bursal disease subviral particles. RSC Adv 2:1970-1978
Wen, Amy M; Ryan, Mary J; Yang, Alice C et al. (2012) Photodynamic activity of viral nanoparticles conjugated with C60. Chem Commun (Camb) 48:9044-6
Wen, Amy M; Lee, Karin L; Yildiz, Ibrahim et al. (2012) Viral nanoparticles for in vivo tumor imaging. J Vis Exp :e4352
Yildiz, Ibrahim; Tsvetkova, Irina; Wen, Amy M et al. (2012) Engineering of Brome mosaic virus for biomedical applications. RSC Adv 2:3670-3677

Showing the most recent 10 out of 13 publications